KR Core Implementation Guide
2.0.0-ballot2 - STU 2

This page is part of the KR Core Implementation Guide (v2.0.0-ballot2: STU 2 Ballot 2) based on FHIR (HL7® FHIR® Standard) R4. This version is a pre-release. The current official version is 1.0.2. For a full list of available versions, see the Directory of published versions

## ValueSet: KR Core Specimen Type Codes

Official URL: http://www.hl7korea.or.kr/fhir/krcore/ValueSet/krcore-specimen-type-codes | Version: 2.0.0-ballot2
Standards status: Trial-use | Computable Name: KR_Core_Specimen_Type_Codes

KR Core 검체 유형 코드집합

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

### Logical Definition (CLD)

- Include all codes defined in `http://loinc.org`

### Expansion

Expansion from tx.fhir.org based on Loinc v2.80

This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown

Code | System | Display (ko)
100000-9 | http://loinc.org | Health informatics pioneer and the father of LOINC
100001-7 | http://loinc.org | Health informatics pioneer and cofounder of LOINC
100002-5 | http://loinc.org | Specimen care is maintained
100003-3 | http://loinc.org | Team communication is maintained throughout care
100004-1 | http://loinc.org | Demonstrates knowledge of the expected psychosocial responses to the procedure
100005-8 | http://loinc.org | Demonstrates knowledge of nutritional management related to the procedure
100006-6 | http://loinc.org | Demonstrates knowledge of medication management
100007-4 | http://loinc.org | Demonstrates knowledge of pain management
10000-8 | http://loinc.org | R wave duration in lead AVR
100008-2 | http://loinc.org | Demonstrates knowledge of wound management
100009-0 | http://loinc.org | Demonstrates knowledge of the procedure and expected results
100010-8 | http://loinc.org | No injury related to procedure equipment, medical supplies, or instrumentation
100011-6 | http://loinc.org | No injury related to an electrical source
100012-4 | http://loinc.org | Participates in decisions affecting the patient's plan of care
100013-2 | http://loinc.org | Participates in the discharge process
100014-0 | http://loinc.org | Psychosocial health is maintained at or improved from baseline
100015-7 | http://loinc.org | No injury related to positioning due to care or procedure
10001-6 | http://loinc.org | R wave duration in lead I
100016-5 | http://loinc.org | No injury related to a laser source
100017-3 | http://loinc.org | Perioperative nursing data set outcomes panel [PNDS]
100018-1 | http://loinc.org | Hospice care Note
100019-9 | http://loinc.org | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100020-7 | http://loinc.org | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100021-5 | http://loinc.org | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100022-3 | http://loinc.org | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100023-1 | http://loinc.org | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10002-4 | http://loinc.org | R wave duration in lead II
100024-9 | http://loinc.org | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100025-6 | http://loinc.org | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100026-4 | http://loinc.org | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100027-2 | http://loinc.org | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100028-0 | http://loinc.org | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100029-8 | http://loinc.org | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method
100030-6 | http://loinc.org | Axis I: Temporal aspects score [Mainz Pain Staging System]
100031-4 | http://loinc.org | Axis II: Spatial aspects score [Mainz Pain Staging System]
10003-2 | http://loinc.org | R wave duration in lead III
100032-2 | http://loinc.org | Axis III: Drug taking behavior score [Mainz Pain Staging System]
100033-0 | http://loinc.org | Axis IV: Utilization of the health care system score [Mainz Pain Staging System]
100034-8 | http://loinc.org | Provider of automated external defibrillator use
100035-5 | http://loinc.org | Exam finding location of Chest
100036-3 | http://loinc.org | Exam finding location of Lung
100037-1 | http://loinc.org | Patient contact disposition EMS unit
100038-9 | http://loinc.org | Patient evaluation disposition EMS unit
100039-7 | http://loinc.org | Crew disposition for patient care EMS unit
10004-0 | http://loinc.org | R wave duration in lead V1
100040-5 | http://loinc.org | Patient transport disposition EMS unit
100041-3 | http://loinc.org | Aminoglycoside [Susceptibility]
100042-1 | http://loinc.org | Atovaquone [Susceptibility]
100043-9 | http://loinc.org | Azithromycin+Ethambutol [Susceptibility]
100044-7 | http://loinc.org | Cefcapene [Susceptibility]
100045-4 | http://loinc.org | Cefozopran [Susceptibility]
100046-2 | http://loinc.org | Cefquinome [Susceptibility]
100047-0 | http://loinc.org | Cefteram [Susceptibility]
100048-8 | http://loinc.org | Clarithromycin+Ethambutol [Susceptibility]
100049-6 | http://loinc.org | Eravacycline [Susceptibility]
100050-4 | http://loinc.org | Erythromycin+Ethambutol [Susceptibility]
100051-2 | http://loinc.org | Ethambutol+rifAMPin [Susceptibility]
100052-0 | http://loinc.org | Flomoxef [Susceptibility]
100053-8 | http://loinc.org | Fluoroquinolone [Susceptibility]
100054-6 | http://loinc.org | Gamithromycin [Susceptibility]
100055-3 | http://loinc.org | Optochin [Susceptibility]
100056-1 | http://loinc.org | Panipenem [Susceptibility]
10005-7 | http://loinc.org | R wave duration in lead V2
100057-9 | http://loinc.org | Prothionamide [Susceptibility]
100058-7 | http://loinc.org | Prulifloxacin [Susceptibility]
100059-5 | http://loinc.org | Rifapentine [Susceptibility]
100060-3 | http://loinc.org | Tildipirosin [Susceptibility]
100061-1 | http://loinc.org | Tosufloxacin [Susceptibility]
100062-9 | http://loinc.org | Standard Dermatology Outcome Measures panel
100063-7 | http://loinc.org | Primary skin concern
100064-5 | http://loinc.org | Itch severity Reporting Period - Reported
10006-5 | http://loinc.org | R wave duration in lead V3
100065-2 | http://loinc.org | Satisfied with treatment
100066-0 | http://loinc.org | Specular microscopy panel
100067-8 | http://loinc.org | Eye Image magnification
100068-6 | http://loinc.org | Right eye Fixation point [Angle]
100069-4 | http://loinc.org | Left eye Fixation point [Angle]
100070-2 | http://loinc.org | Right cornea Cell density
100071-0 | http://loinc.org | Left cornea Cell density
100072-8 | http://loinc.org | Right cornea Coefficient of variation
10007-3 | http://loinc.org | R wave duration in lead V4
100073-6 | http://loinc.org | Left cornea Coefficient of variation
100074-4 | http://loinc.org | Right cornea Hexagonality
100075-1 | http://loinc.org | Left cornea Hexagonality
100076-9 | http://loinc.org | Right cornea Endothelial cells counted
100077-7 | http://loinc.org | Left cornea Endothelial cells counted
100078-5 | http://loinc.org | Right cornea Endothelial cell area.min
100079-3 | http://loinc.org | Left cornea Endothelial cell area.min
100080-1 | http://loinc.org | Right cornea Endothelial cell area.max
10008-1 | http://loinc.org | R wave duration in lead V5
100081-9 | http://loinc.org | Left cornea Endothelial cell area.max
100082-7 | http://loinc.org | Right cornea Endothelial cell area.mean
100083-5 | http://loinc.org | Left cornea Endothelial cell area.mean
100084-3 | http://loinc.org | Right cornea Cell area.standard deviation
100085-0 | http://loinc.org | Left cornea Cell area.standard deviation
100086-8 | http://loinc.org | Right cornea Type of Analysis method by Specular microscopy
100087-6 | http://loinc.org | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot
100088-4 | http://loinc.org | Taenia solium larva Ab bands panel - Serum by Immunoblot
100089-2 | http://loinc.org | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot
1000-9 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Blood product unit
100090-0 | http://loinc.org | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot
100091-8 | http://loinc.org | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay
100092-6 | http://loinc.org | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot
100093-4 | http://loinc.org | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot
100094-2 | http://loinc.org | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot
100095-9 | http://loinc.org | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot
100096-7 | http://loinc.org | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot
100097-5 | http://loinc.org | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot
100098-3 | http://loinc.org | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot
10009-9 | http://loinc.org | R wave duration in lead V6
100099-1 | http://loinc.org | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot
100100-7 | http://loinc.org | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay
100101-5 | http://loinc.org | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot
100102-3 | http://loinc.org | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot
100103-1 | http://loinc.org | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot
100104-9 | http://loinc.org | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot
100105-6 | http://loinc.org | Filaria IgG and IgM panel - Serum
100106-4 | http://loinc.org | Filaria IgG Ab [Presence] in Serum by Immunoassay
10010-7 | http://loinc.org | R' wave amplitude in lead AVF
100107-2 | http://loinc.org | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay
100108-0 | http://loinc.org | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay
100109-8 | http://loinc.org | Leishmania sp Ab bands panel - Serum by Immunoblot
100110-6 | http://loinc.org | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot
100111-4 | http://loinc.org | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot
100112-2 | http://loinc.org | Fasciola sp Ab bands panel - Serum by Immunoblot
100113-0 | http://loinc.org | Helicobacter pylori Ab panel - Serum
100114-8 | http://loinc.org | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot
10011-5 | http://loinc.org | R' wave amplitude in lead AVL
100115-5 | http://loinc.org | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot
100116-3 | http://loinc.org | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot
100117-1 | http://loinc.org | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot
100118-9 | http://loinc.org | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot
100119-7 | http://loinc.org | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot
100120-5 | http://loinc.org | Chlamydia trachomatis Ab panel - Serum
100121-3 | http://loinc.org | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay
100122-1 | http://loinc.org | Chlamydophila pneumoniae Ab panel - Serum
10012-3 | http://loinc.org | R' wave amplitude in lead AVR
100123-9 | http://loinc.org | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay
100124-7 | http://loinc.org | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay
100125-4 | http://loinc.org | Chlamydophila psittaci Ab panel - Serum
100126-2 | http://loinc.org | Bordetella pertussis Ab.IgG panel - Serum
100127-0 | http://loinc.org | Campylobacter sp Ab panel - Serum
100128-8 | http://loinc.org | Cryptococcus sp Ag panel - Serum
100129-6 | http://loinc.org | Schistosoma sp Ab [Titer] in Serum by Hemagglutination
100130-4 | http://loinc.org | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot
10013-1 | http://loinc.org | R' wave amplitude in lead I
100131-2 | http://loinc.org | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot
100132-0 | http://loinc.org | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot
100133-8 | http://loinc.org | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot
100134-6 | http://loinc.org | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot
100135-3 | http://loinc.org | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot
100136-1 | http://loinc.org | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot
100137-9 | http://loinc.org | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot
100138-7 | http://loinc.org | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot
100139-5 | http://loinc.org | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot
100140-3 | http://loinc.org | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot
100141-1 | http://loinc.org | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot
100142-9 | http://loinc.org | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot
100143-7 | http://loinc.org | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot
100144-5 | http://loinc.org | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot
100145-2 | http://loinc.org | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot
100146-0 | http://loinc.org | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot
100147-8 | http://loinc.org | Toxoplasma gondii Ab bands panel - Serum by Immunoblot
100148-6 | http://loinc.org | Schistosoma sp Ab bands panel - Serum by Immunoblot
10014-9 | http://loinc.org | R' wave amplitude in lead II
100149-4 | http://loinc.org | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma
100150-2 | http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma
100151-0 | http://loinc.org | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma
100152-8 | http://loinc.org | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
100153-6 | http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
100154-4 | http://loinc.org | Specimen collection supervision level
100155-1 | http://loinc.org | Left cornea Type of Analysis method by Specular microscopy
10015-6 | http://loinc.org | R' wave amplitude in lead III
100156-9 | http://loinc.org | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
100157-7 | http://loinc.org | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
100158-5 | http://loinc.org | Microalbumin [Mass/volume] in Urine collected for unspecified duration
100159-3 | http://loinc.org | Knee Society Score pre-op panel [Knee Society Score]
100160-1 | http://loinc.org | Knee replacement
100161-9 | http://loinc.org | Charnley Functional Classification
100162-7 | http://loinc.org | Knee alignment W standing X-ray measured
100163-5 | http://loinc.org | Knee medial AndOr lateral instability W full extension
10016-4 | http://loinc.org | R' wave amplitude in lead V1
100164-3 | http://loinc.org | Knee AP instability W 90 degree flexion
100165-0 | http://loinc.org | Knee range of motion
100166-8 | http://loinc.org | Flexion contracture range of Knee
100167-6 | http://loinc.org | Extensor lag range of Knee
100168-4 | http://loinc.org | Knee pain severity with level walking
100169-2 | http://loinc.org | Knee pain severity with stairs or inclines
1001-7 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Donor
100170-0 | http://loinc.org | Knee feels normal
100171-8 | http://loinc.org | Satisfaction with level of knee pain while sitting
10017-2 | http://loinc.org | R' wave amplitude in lead V2
100172-6 | http://loinc.org | Satisfaction with level of knee pain while lying in bed
100173-4 | http://loinc.org | Satisfaction with knee function while getting out of bed
100174-2 | http://loinc.org | Satisfaction with knee function while performing light household duties
100175-9 | http://loinc.org | Satisfaction with knee function while performing recreational activities
100176-7 | http://loinc.org | Expect surgery to relieve pain
100177-5 | http://loinc.org | Expect surgery will improve ability to perform activities of daily living
100178-3 | http://loinc.org | Expect surgery will improve ability to perform leisure, recreational, or sports activities
100179-1 | http://loinc.org | Walk without assistive mobility devices
10018-0 | http://loinc.org | R' wave amplitude in lead V3
100180-9 | http://loinc.org | Assistive mobility devices used
100181-7 | http://loinc.org | Assistive mobility devices used due to health condition
100182-5 | http://loinc.org | Duration of standing before sitting due to knee discomfort
100183-3 | http://loinc.org | Duration of walking before stopping due to knee discomfort
100184-1 | http://loinc.org | How bothersome is knee when walking on an uneven surface
100185-8 | http://loinc.org | How bothersome is knee when turning or pivoting leg
100186-6 | http://loinc.org | How bothersome is knee when climbing up or down a flight of stairs
100187-4 | http://loinc.org | How bothersome is knee when getting up from a low seat without armrests
100188-2 | http://loinc.org | How bothersome is knee when getting into or out of a car
100189-0 | http://loinc.org | How bothersome is knee when moving laterally
100190-8 | http://loinc.org | How bothersome is knee when climbing a ladder or step stool
100191-6 | http://loinc.org | How bothersome is knee when carrying a bag for one block
100192-4 | http://loinc.org | How bothersome is knee when squatting
100193-2 | http://loinc.org | How bothersome is knee when kneeling
100194-0 | http://loinc.org | How bothersome is knee when running
100195-7 | http://loinc.org | Pain severity--during activity
100196-5 | http://loinc.org | Pre-op total score [Knee Society Score]
100197-3 | http://loinc.org | Exercise activity and pain severity panel
10019-8 | http://loinc.org | R' wave amplitude in lead V4
100198-1 | http://loinc.org | Pre-op objective knee indicators score [Knee Society Score]
100199-9 | http://loinc.org | Pre-op symptoms score [Knee Society Score]
100200-5 | http://loinc.org | Pre-op patient expectations score [Knee Society Score]
100201-3 | http://loinc.org | Pre-op functional activities score [Knee Society Score]
100202-1 | http://loinc.org | Pre-op discretionary knee activities score [Knee Society Score]
100203-9 | http://loinc.org | Knee Society Score post-op panel [Knee Society Score]
100204-7 | http://loinc.org | Accuracy of pre-surgery expectations of pain relief
100205-4 | http://loinc.org | Accuracy of pre-surgery expectations to perform activities of daily living
10020-6 | http://loinc.org | R' wave amplitude in lead V5
100206-2 | http://loinc.org | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities
100207-0 | http://loinc.org | Post-op total score [Knee Society Score]
100208-8 | http://loinc.org | Post-op objective knee indicators score [Knee Society Score]
100209-6 | http://loinc.org | Post-op symptoms score [Knee Society Score]
100210-4 | http://loinc.org | Post-op patient expectations score [Knee Society Score]
100211-2 | http://loinc.org | Post-op functional activities score [Knee Society Score]
100212-0 | http://loinc.org | Post-op discretionary knee activities score [Knee Society Score]
100213-8 | http://loinc.org | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method
10021-4 | http://loinc.org | R' wave amplitude in lead V6
100214-6 | http://loinc.org | Dental model prior authorization Document
100215-3 | http://loinc.org | Episode of care medical records Document Transplant surgery
100216-1 | http://loinc.org | Surgical synoptic report
100217-9 | http://loinc.org | Synoptic report Narrative Surgical oncology
100218-7 | http://loinc.org | Surgical oncology of colon cancer synoptic report
100219-5 | http://loinc.org | Surgical oncology of melanoma cancer synoptic report
100220-3 | http://loinc.org | Surgical oncology of breast cancer synoptic report
100221-1 | http://loinc.org | Surgical oncology of thyroid cancer synoptic report
10022-2 | http://loinc.org | R' wave duration in lead AVF
100222-9 | http://loinc.org | Surgical oncology of pancreas cancer synoptic report
100223-7 | http://loinc.org | Physical findings of Retina Narrative
100224-5 | http://loinc.org | Cardiac left ventricular segmental wall motion by echo panel
100225-2 | http://loinc.org | Bone density quantitative ultrasound study
100226-0 | http://loinc.org | Small bowel capsule endoscopy study Document
100227-8 | http://loinc.org | Colon capsule endoscopy study Document
100228-6 | http://loinc.org | Upper gastrointestinal capsule endoscopy study Document
100229-4 | http://loinc.org | Endoscopic ultrasound study Document
10023-0 | http://loinc.org | R' wave duration in lead AVL
100230-2 | http://loinc.org | Routine prenatal assessment panel
100231-0 | http://loinc.org | Endobronchial ultrasound study
100232-8 | http://loinc.org | Impacts of Events Scale-Revised panel
100233-6 | http://loinc.org | Reminders brought back feelings about adverse event
100234-4 | http://loinc.org | Trouble staying asleep
100235-1 | http://loinc.org | Other things triggered persistent thoughts about adverse event
100236-9 | http://loinc.org | Felt irritable AndOr angry
100237-7 | http://loinc.org | Avoided getting upset when unintentionally thought about adverse event
100238-5 | http://loinc.org | Thought about adverse event unintentionally
100239-3 | http://loinc.org | Felt as if adverse event did not happen
100240-1 | http://loinc.org | Avoided reminders of adverse event
100241-9 | http://loinc.org | Experienced mental images of adverse event
100242-7 | http://loinc.org | Easily startled
100243-5 | http://loinc.org | Tried to not think of adverse event
100244-3 | http://loinc.org | Aware of feelings about adverse event, but did not address them
100245-0 | http://loinc.org | Feelings about adverse event were numb
100246-8 | http://loinc.org | Acted or felt the same as during adverse event
100247-6 | http://loinc.org | Trouble falling asleep
10024-8 | http://loinc.org | R' wave duration in lead AVR
100248-4 | http://loinc.org | Waves of strong feelings about adverse event
100249-2 | http://loinc.org | Tried to remove adverse event from memory
1002-5 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma
100250-0 | http://loinc.org | Trouble concentrating
100251-8 | http://loinc.org | Reminders of adverse event caused physical reactions
100252-6 | http://loinc.org | Had dreams about adverse event
100253-4 | http://loinc.org | Felt watchful and on-guard
100254-2 | http://loinc.org | Tried not to talk about adverse event
10025-5 | http://loinc.org | R' wave duration in lead I
100255-9 | http://loinc.org | Total score [Impact of Event Scale-Revised]
100256-7 | http://loinc.org | Fallen in last 6 months
100257-5 | http://loinc.org | Feel unsteady when standing or walking
100258-3 | http://loinc.org | History of fall related injury
100259-1 | http://loinc.org | Aware of tactile sensations
100260-9 | http://loinc.org | Easy to describe thoughts AndOr feelings
100261-7 | http://loinc.org | Critical of own thoughts AndOr feelings
100262-5 | http://loinc.org | Able to notice distressing thoughts AndOr feelings without having to react
10026-3 | http://loinc.org | R' wave duration in lead II
100263-3 | http://loinc.org | Easily distracted
100264-1 | http://loinc.org | Able to notice thoughts AndOr feelings without being overwhelmed
100265-8 | http://loinc.org | Aware of dietary intake impact on self
100266-6 | http://loinc.org | Difficult to describe thoughts AndOr feelings
100267-4 | http://loinc.org | Aware of auditory stimuli
100268-2 | http://loinc.org | Able to avoid immediate reaction in difficult situations
100269-0 | http://loinc.org | Do things without paying attention
100270-8 | http://loinc.org | Recover quickly from distressing thoughts AndOr images
10027-1 | http://loinc.org | R' wave duration in lead III
100271-6 | http://loinc.org | Aware of olfactory stimuli
100272-4 | http://loinc.org | Aware of visual stimuli
100273-2 | http://loinc.org | Aware of emotions affect on thoughts AndOr behavior
100274-0 | http://loinc.org | Observing score [FFMQ]
100275-7 | http://loinc.org | Describing score [FFMQ]
100276-5 | http://loinc.org | Acting with awareness score [FFMQ]
100277-3 | http://loinc.org | Nonjudging score [FFMQ]
100278-1 | http://loinc.org | Nonreactivity score [FFMQ]
100279-9 | http://loinc.org | Total score [FFMQ]
100280-7 | http://loinc.org | Five Facet Mindfulness Questionnaire panel [FFMQ]
100281-5 | http://loinc.org | D Ab [Units/volume] in Serum or Plasma
100282-3 | http://loinc.org | Vaccine exemption certificate
100283-1 | http://loinc.org | Harris Hip Score panel [Harris Hip Score]
100284-9 | http://loinc.org | Walking - functional ability
100285-6 | http://loinc.org | Comfortable seated position
100286-4 | http://loinc.org | Able to board public transportation
100287-2 | http://loinc.org | Put on shoes and socks
100288-0 | http://loinc.org | Absence of deformity score [Harris Hip Score]
10028-9 | http://loinc.org | R' wave duration in lead V1
100289-8 | http://loinc.org | Absence of hip deformity measurements
100290-6 | http://loinc.org | Range of motion score [Harris Hip Score]
100291-4 | http://loinc.org | Total score [Harris Hip Score]
100292-2 | http://loinc.org | Pre-op patient satisfaction score [Knee Society Score]
100293-0 | http://loinc.org | Hip Flexion range of motion
100294-8 | http://loinc.org | Hip Abduction range of motion
100295-5 | http://loinc.org | Hip Adduction range of motion
100296-3 | http://loinc.org | Hip External rotation range of motion
10029-7 | http://loinc.org | R' wave duration in lead V2
100297-1 | http://loinc.org | Hip Internal rotation range of motion
100298-9 | http://loinc.org | Repetition count
100299-7 | http://loinc.org | Post-op patient satisfaction score [Knee Society Score]
100300-3 | http://loinc.org | End time Unspecified body region
100301-1 | http://loinc.org | Start time Unspecified body region
100302-9 | http://loinc.org | Time period start and end panel Unspecified body region
100303-7 | http://loinc.org | Condition certainty of presence
100304-5 | http://loinc.org | Flights climbed [#] Reporting Period
10030-5 | http://loinc.org | R' wave duration in lead V3
100305-2 | http://loinc.org | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
100306-0 | http://loinc.org | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
100307-8 | http://loinc.org | Behavioral screening elder mistreatment
100308-6 | http://loinc.org | Need help getting to essential places
100309-4 | http://loinc.org | Activity support person
100310-2 | http://loinc.org | Reliability of support person
100311-0 | http://loinc.org | Need help to make sure there is enough food, medicines or any other things needed in house
100312-8 | http://loinc.org | Person or persons that makes sure there is enough food, medicines or any other things needed in house
10031-3 | http://loinc.org | R' wave duration in lead V4
100313-6 | http://loinc.org | Need help with household things such as cook meals, help feed, or provide correct medicines each day
100314-4 | http://loinc.org | Need help with house cleaning or yard work
100315-1 | http://loinc.org | Need help getting out of bed, showered, or dressed
100316-9 | http://loinc.org | Need help to make sure bills get paid
100317-7 | http://loinc.org | Relationship of usual support person for daily activities
100318-5 | http://loinc.org | Have help with finances AndOr financial decisions
100319-3 | http://loinc.org | Relationship of financial support person
100320-1 | http://loinc.org | Financial support person usually asks for permission before making decisions
10032-1 | http://loinc.org | R' wave duration in lead V5
100321-9 | http://loinc.org | Financial support person usually makes good decisions about finances
100322-7 | http://loinc.org | Have access to paperwork for financial decisions made
100323-5 | http://loinc.org | Financial support person forged signature
100324-3 | http://loinc.org | Coercion of financial support person for signing a document in order to get money or possessions
100325-0 | http://loinc.org | Experienced theft by support person
100326-8 | http://loinc.org | Money spent or property sold without permission
100327-6 | http://loinc.org | Stranger forged signature for financial gain
100328-4 | http://loinc.org | Stranger forced document signature for financial gain
100329-2 | http://loinc.org | Feared for safety due to verbal attack
1003-3 | http://loinc.org | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma
100330-0 | http://loinc.org | Felt humiliated due to ridicule
100331-8 | http://loinc.org | Coerced to do something
100332-6 | http://loinc.org | Ignored by close friend or relative for extended period
100333-4 | http://loinc.org | Physically hit or threatened
100334-2 | http://loinc.org | Been physically hurt with some degree of injury
100335-9 | http://loinc.org | Coerced sexual activity
100336-7 | http://loinc.org | Coerced touching of private body parts of self or others
100337-5 | http://loinc.org | Coerced to undress or expose private body area
100338-3 | http://loinc.org | Photographed in any degree of nudity without consent
10033-9 | http://loinc.org | R' wave duration in lead V6
100339-1 | http://loinc.org | Experienced attempted physical restraint
100340-9 | http://loinc.org | Range of motion panel Hip
100341-7 | http://loinc.org | Rubella virus IgG Ab index [Units/volume] in Serum and CSF
100342-5 | http://loinc.org | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry
100343-3 | http://loinc.org | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
100344-1 | http://loinc.org | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
100345-8 | http://loinc.org | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
100346-6 | http://loinc.org | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG
10034-7 | http://loinc.org | S wave amplitude in lead AVF
100347-4 | http://loinc.org | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG
100348-2 | http://loinc.org | Model for end-stage liver disease sodium score
100349-0 | http://loinc.org | US.doppler Penis vessels W vasodilator IV
100350-8 | http://loinc.org | Sesamum indicum 1 IgE Ab [Units/volume] in Serum
100351-6 | http://loinc.org | Pioglitazone [Presence] in Serum or Plasma
100352-4 | http://loinc.org | Rosiglitazone [Presence] in Serum or Plasma
100353-2 | http://loinc.org | Norwalk Community Health Center Screening Tool [NCHC]
10035-4 | http://loinc.org | S wave amplitude in lead AVL
100354-0 | http://loinc.org | Frequency of participating in multi-modal communication without assistance
100355-7 | http://loinc.org | Frequency of participating in spoken language expression communication without assistance
100356-5 | http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection
100357-3 | http://loinc.org | Naloxone [Presence] in Cord tissue by Screen method
100358-1 | http://loinc.org | Phentermine [Presence] in Cord tissue by Screen method
100359-9 | http://loinc.org | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay
100360-7 | http://loinc.org | Brief Resilience Scale panel [BRS]
100361-5 | http://loinc.org | Quickly recover from bad events
10036-2 | http://loinc.org | S wave amplitude in lead AVR
100362-3 | http://loinc.org | Difficulty making it through stressful events
100363-1 | http://loinc.org | Easily recover from a stressful event
100364-9 | http://loinc.org | Difficulty recovering from bad events
100365-6 | http://loinc.org | Easily recover from difficulties
100366-4 | http://loinc.org | Lengthy recovery from setbacks
100367-2 | http://loinc.org | Total Score BRS
100368-0 | http://loinc.org | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS
100369-8 | http://loinc.org | NM Thyroid gland Views W Tl-201 IV
10037-0 | http://loinc.org | S wave amplitude in lead I
100370-6 | http://loinc.org | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection
100371-4 | http://loinc.org | Titin Ab [Units/volume] in Serum by Immunoassay
100372-2 | http://loinc.org | Abiraterone [Mass/volume] in Serum or Plasma
100373-0 | http://loinc.org | Eucheuma IgG Ab [Units/volume] in Serum
100374-8 | http://loinc.org | Aloe vera IgG Ab [Units/volume] in Serum
100375-5 | http://loinc.org | Anise IgG Ab [Units/volume] in Serum
100376-3 | http://loinc.org | Bambusa vulgaris IgG Ab [Units/volume] in Serum
100377-1 | http://loinc.org | Goat cheese IgG Ab [Units/volume] in Serum
100378-9 | http://loinc.org | Sheep cheese IgG Ab [Units/volume] in Serum
100379-7 | http://loinc.org | Leeks IgG Ab [Units/volume] in Serum
100380-5 | http://loinc.org | Red cabbage IgG Ab [Units/volume] in Serum
100381-3 | http://loinc.org | Mentha balsamea Wild IgG Ab [Units/volume] in Serum
100382-1 | http://loinc.org | FDA package insert REMS addressed risk
100383-9 | http://loinc.org | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection
100384-7 | http://loinc.org | Rapeseed IgG Ab [Units/volume] in Serum
100385-4 | http://loinc.org | Corn salad IgG Ab [Units/volume] in Serum
100386-2 | http://loinc.org | Rosemary IgG Ab [Units/volume] in Serum
100387-0 | http://loinc.org | Poppy Seed IgG Ab [Units/volume] in Serum
10038-8 | http://loinc.org | S wave amplitude in lead II
100388-8 | http://loinc.org | Cocoa IgG Ab [Units/volume] in Serum
100389-6 | http://loinc.org | Pistachio IgG Ab [Units/volume] in Serum
100390-4 | http://loinc.org | Sunflower Seed IgG Ab [Units/volume] in Serum
100391-2 | http://loinc.org | Dates IgG Ab [Units/volume] in Serum
100392-0 | http://loinc.org | Duck meat IgG Ab [Units/volume] in Serum
100393-8 | http://loinc.org | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum
100394-6 | http://loinc.org | Astacoidea IgG Ab [Units/volume] in Serum
100395-3 | http://loinc.org | Carob IgG Ab [Units/volume] in Serum
10039-6 | http://loinc.org | S wave amplitude in lead III
100396-1 | http://loinc.org | Brassica napus IgG Ab [Units/volume] in Serum
100397-9 | http://loinc.org | Goat Meat IgG Ab [Units/volume] in Serum
100398-7 | http://loinc.org | Goose meat IgG Ab [Units/volume] in Serum
100399-5 | http://loinc.org | Ostrich meat IgG Ab [Units/volume] in Serum
100400-1 | http://loinc.org | Quail meat IgG Ab [Units/volume] in Serum
100401-9 | http://loinc.org | Rabbit meat IgG Ab [Units/volume] in Serum
100402-7 | http://loinc.org | Venison meat IgG Ab [Units/volume] in Serum
100403-5 | http://loinc.org | Guineafowl IgG Ab [Units/volume] in Serum
10040-4 | http://loinc.org | S wave amplitude in lead V1
100404-3 | http://loinc.org | Horse meat IgG Ab [Units/volume] in Serum
100405-0 | http://loinc.org | Kefir IgG Ab [Units/volume] in Serum
100406-8 | http://loinc.org | Butter IgG Ab [Units/volume] in Serum
100407-6 | http://loinc.org | Camembert cheese IgG Ab [Units/volume] in Serum
100408-4 | http://loinc.org | Emmental cheese IgG Ab [Units/volume] in Serum
100409-2 | http://loinc.org | Processed cheese IgG Ab [Units/volume] in Serum
1004-1 | http://loinc.org | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells
100410-0 | http://loinc.org | Curd cheese IgG Ab [Units/volume] in Serum
100411-8 | http://loinc.org | Sugar Beet IgG Ab [Units/volume] in Serum
10041-2 | http://loinc.org | S wave amplitude in lead V2
100412-6 | http://loinc.org | Chinese cabbage IgG Ab [Units/volume] in Serum
100413-4 | http://loinc.org | Fennel Fresh IgG Ab [Units/volume] in Serum
100414-2 | http://loinc.org | Gourd IgG Ab [Units/volume] in Serum
100415-9 | http://loinc.org | Kale IgG Ab [Units/volume] in Serum
100416-7 | http://loinc.org | Savoy cabbage IgG Ab [Units/volume] in Serum
100417-5 | http://loinc.org | Vitis sp leaf IgG Ab [Units/volume] in Serum
100418-3 | http://loinc.org | Liquorice IgG Ab [Units/volume] in Serum
100419-1 | http://loinc.org | Snow pea IgG Ab [Units/volume] in Serum
10042-0 | http://loinc.org | S wave amplitude in lead V3
100420-9 | http://loinc.org | Fava bean IgG Ab [Units/volume] in Serum
100421-7 | http://loinc.org | Chick Pea IgG Ab [Units/volume] in Serum
100422-5 | http://loinc.org | Chicory IgG Ab [Units/volume] in Serum
100423-3 | http://loinc.org | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum
100424-1 | http://loinc.org | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma
100425-8 | http://loinc.org | DiHydro T-Mas [Mass/volume] in Serum or Plasma
100426-6 | http://loinc.org | Squalene [Mass/volume] in Serum or Plasma
100427-4 | http://loinc.org | Stigmasterol [Mass/volume] in Serum or Plasma
100428-2 | http://loinc.org | Carnitine free and total and acylcarnitine panel - Urine
100429-0 | http://loinc.org | LRBA deficiency panel - Blood
100430-8 | http://loinc.org | Cells.LRBA+/Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC)
100431-6 | http://loinc.org | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
100432-4 | http://loinc.org | Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC)
100433-2 | http://loinc.org | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
100434-0 | http://loinc.org | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection
100435-7 | http://loinc.org | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay
100436-5 | http://loinc.org | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay
100437-3 | http://loinc.org | Norsufentanil [Mass/volume] in Urine by Confirmatory method
10043-8 | http://loinc.org | S wave amplitude in lead V4
100438-1 | http://loinc.org | Adolescent medicine Outpatient Progress note
100439-9 | http://loinc.org | Allergy and Immunology Outpatient Progress note
100440-7 | http://loinc.org | Allergy Outpatient Progress note
100441-5 | http://loinc.org | Attending Outpatient Progress note
100442-3 | http://loinc.org | Audiology Outpatient Progress note
100443-1 | http://loinc.org | Bariatric surgery Outpatient Progress note
100444-9 | http://loinc.org | Blood banking and transfusion medicine Outpatient Progress note
100445-6 | http://loinc.org | Bone Marrow Transplant Outpatient Progress note
10044-6 | http://loinc.org | S wave amplitude in lead V5
100446-4 | http://loinc.org | Breastfeeding Outpatient Progress note
100447-2 | http://loinc.org | Burn management Outpatient Progress note
100448-0 | http://loinc.org | Cardiac surgery Outpatient Progress note
100449-8 | http://loinc.org | Cardiopulmonary Outpatient Progress note
100450-6 | http://loinc.org | Child and adolescent psychiatry Outpatient Progress note
100451-4 | http://loinc.org | Chiropractic medicine Outpatient Progress note
100452-2 | http://loinc.org | Clinical cardiac electrophysiology Outpatient Progress note
10045-3 | http://loinc.org | S wave amplitude in lead V6
100453-0 | http://loinc.org | Clinical genetics Outpatient Progress note
100454-8 | http://loinc.org | Clinical neurophysiology Outpatient Progress note
100455-5 | http://loinc.org | Clinical pathology Outpatient Progress note
100456-3 | http://loinc.org | Colon and rectal surgery Outpatient Progress note
100457-1 | http://loinc.org | Consultant Outpatient Progress note
100458-9 | http://loinc.org | Outpatient COVID-19 Intubation Progress note
100459-7 | http://loinc.org | Outpatient COVID-19 Progress note
100460-5 | http://loinc.org | Dermatology Outpatient Progress note
10046-1 | http://loinc.org | S wave duration in lead AVF
100461-3 | http://loinc.org | Developmental-behavioral pediatrics Outpatient Progress note
100462-1 | http://loinc.org | Dialysis and Therapeutic apheresis Outpatient Progress note
100463-9 | http://loinc.org | Eating disorders Outpatient Progress note
100464-7 | http://loinc.org | Endocrinology Outpatient Progress note
100465-4 | http://loinc.org | Family medicine Outpatient Progress note
100466-2 | http://loinc.org | Gastroenterology Outpatient Progress note
100467-0 | http://loinc.org | Geriatric medicine Outpatient Progress note
100468-8 | http://loinc.org | Gynecologic oncology Outpatient Progress note
100469-6 | http://loinc.org | Gynecology Outpatient Progress note
100470-4 | http://loinc.org | Healthcare navigator Outpatient Progress note
100471-2 | http://loinc.org | Heart failure Outpatient Progress note
100472-0 | http://loinc.org | Heart failure+Transplant cardiology Outpatient Progress note
100473-8 | http://loinc.org | Hematology Outpatient Progress note
100474-6 | http://loinc.org | Hematology+Medical oncology Outpatient Progress note
100475-3 | http://loinc.org | Hepatology Outpatient Progress note
100476-1 | http://loinc.org | Immunology Outpatient Progress note
100477-9 | http://loinc.org | Infectious disease Outpatient Progress note
100478-7 | http://loinc.org | Internal medicine Outpatient Progress note
10047-9 | http://loinc.org | S wave duration in lead AVL
100479-5 | http://loinc.org | Interventional cardiology Outpatient Progress note
100480-3 | http://loinc.org | Interventional radiology Outpatient Progress note
100481-1 | http://loinc.org | Outpatient Mechanical circulatory support Progress note
100482-9 | http://loinc.org | Medical Aid in Dying Outpatient Progress note
100483-7 | http://loinc.org | Mental health Outpatient Progress note
100484-5 | http://loinc.org | Multi-specialty program Outpatient Progress note
100485-2 | http://loinc.org | Neonatal perinatal medicine Outpatient Progress note
100486-0 | http://loinc.org | Nephrology Outpatient Progress note
10048-7 | http://loinc.org | S wave duration in lead AVR
100487-8 | http://loinc.org | Neurological surgery Outpatient Progress note
100488-6 | http://loinc.org | Neurology Outpatient Progress note
100489-4 | http://loinc.org | Neurology with special qualifications in child neurology Outpatient Progress note
100490-2 | http://loinc.org | Nurse practitioner Outpatient Progress note
100491-0 | http://loinc.org | Nurse Outpatient Progress note
100492-8 | http://loinc.org | Nutrition and dietetics Outpatient Progress note
100493-6 | http://loinc.org | Obstetrics and Gynecology Outpatient Progress note
100494-4 | http://loinc.org | Obstetrics Outpatient Progress note
10049-5 | http://loinc.org | S wave duration in lead I
100495-1 | http://loinc.org | Occupational therapy Outpatient Progress note
100496-9 | http://loinc.org | Oncology Outpatient Progress note
100497-7 | http://loinc.org | Ophthalmology Outpatient Progress note
100498-5 | http://loinc.org | Optometry Outpatient Progress note
100499-3 | http://loinc.org | Oral and Maxillofacial Surgery Outpatient Progress note
100500-8 | http://loinc.org | Orthopaedic surgery Outpatient Progress note
100501-6 | http://loinc.org | Orthotics prosthetics Outpatient Progress note
100502-4 | http://loinc.org | Otolaryngology Outpatient Progress note
10050-3 | http://loinc.org | S wave duration in lead II
100503-2 | http://loinc.org | Pain medicine Outpatient Progress note
100504-0 | http://loinc.org | Palliative care Outpatient Progress note
100505-7 | http://loinc.org | Pediatric cardiology Outpatient Progress note
100506-5 | http://loinc.org | Pediatric dermatology Outpatient Progress note
100507-3 | http://loinc.org | Pediatric endocrinology Outpatient Progress note
100508-1 | http://loinc.org | Pediatric gastroenterology Outpatient Progress note
100509-9 | http://loinc.org | Pediatric hematology-oncology Outpatient Progress note
100510-7 | http://loinc.org | Pediatric infectious diseases Outpatient Progress note
10051-1 | http://loinc.org | S wave duration in lead III
100511-5 | http://loinc.org | Pediatric otolaryngology Outpatient Progress note
100512-3 | http://loinc.org | Pediatric pulmonology Outpatient Progress note
100513-1 | http://loinc.org | Pediatric rheumatology Outpatient Progress note
100514-9 | http://loinc.org | Pediatric surgery Outpatient Progress note
100515-6 | http://loinc.org | Pediatric transplant hepatology Outpatient Progress note
100516-4 | http://loinc.org | Pediatric urology Outpatient Progress note
100517-2 | http://loinc.org | Pharmacogenomics Outpatient Progress note
100518-0 | http://loinc.org | Physical medicine and rehab Outpatient Progress note
100519-8 | http://loinc.org | Physical therapy Outpatient Progress note
100520-6 | http://loinc.org | Plastic surgery Outpatient Progress note
100521-4 | http://loinc.org | Podiatry Outpatient Progress note
100522-2 | http://loinc.org | Psychiatry Hospital Progress note
100523-0 | http://loinc.org | Psychology Outpatient Progress note
100524-8 | http://loinc.org | Pulmonary Outpatient Progress note
100525-5 | http://loinc.org | Radiation oncology Outpatient Progress note
100526-3 | http://loinc.org | Radiology Outpatient Progress note
100527-1 | http://loinc.org | Recreational therapy Outpatient Progress note
100528-9 | http://loinc.org | Reproductive endocrinology and infertility Outpatient Progress note
10052-9 | http://loinc.org | S wave duration in lead V1
100529-7 | http://loinc.org | Research Outpatient Progress note
100530-5 | http://loinc.org | Rheumatology Outpatient Progress note
100531-3 | http://loinc.org | Sleep medicine Outpatient Progress note
100532-1 | http://loinc.org | Social worker Outpatient Progress note
100533-9 | http://loinc.org | Solid Organ Transplant Outpatient Progress note
100534-7 | http://loinc.org | Speech-language pathology Outpatient Progress note
100535-4 | http://loinc.org | Spinal surgery Outpatient Progress note
100536-2 | http://loinc.org | Sports medicine Outpatient Progress note
10053-7 | http://loinc.org | S wave duration in lead V2
100537-0 | http://loinc.org | Surgery of the hand Outpatient Progress note
100538-8 | http://loinc.org | Telehealth+Outpatient Progress note
100539-6 | http://loinc.org | Thromboembolism Outpatient Progress note
100540-4 | http://loinc.org | Transplant surgery Outpatient Progress note
100541-2 | http://loinc.org | Trauma Outpatient Progress note
100542-0 | http://loinc.org | Urology Outpatient Progress note
100543-8 | http://loinc.org | Vascular neurology Outpatient Progress note
100544-6 | http://loinc.org | Vascular surgery Outpatient Progress note
10054-5 | http://loinc.org | S wave duration in lead V3
100545-3 | http://loinc.org | Wound care management Outpatient Progress note
100546-1 | http://loinc.org | Wound, Ostomy, and Continence Care Outpatient Progress note
100547-9 | http://loinc.org | Adolescent medicine Hospital Progress note
100548-7 | http://loinc.org | Allergy and Immunology Hospital Progress note
100549-5 | http://loinc.org | Allergy Hospital Progress note
100550-3 | http://loinc.org | Attending Hospital Progress note
100551-1 | http://loinc.org | Audiology Hospital Progress note
10055-2 | http://loinc.org | S wave duration in lead V4
100552-9 | http://loinc.org | Bariatric surgery Hospital Progress note
100553-7 | http://loinc.org | Blood banking and transfusion medicine Hospital Progress note
100554-5 | http://loinc.org | Bone Marrow Transplant Hospital Progress note
100555-2 | http://loinc.org | Breastfeeding Hospital Progress note
100556-0 | http://loinc.org | Burn management Hospital Progress note
100557-8 | http://loinc.org | Cardiac surgery Hospital Progress note
100558-6 | http://loinc.org | Cardiopulmonary Hospital Progress note
100559-4 | http://loinc.org | Child and adolescent psychiatry Hospital Progress note
10056-0 | http://loinc.org | S wave duration in lead V5
100560-2 | http://loinc.org | Clinical cardiac electrophysiology Hospital Progress note
100561-0 | http://loinc.org | Clinical genetics Hospital Progress note
100562-8 | http://loinc.org | Clinical neurophysiology Hospital Progress note
100563-6 | http://loinc.org | Clinical pathology Hospital Progress note
100564-4 | http://loinc.org | Colon and rectal surgery Hospital Progress note
100565-1 | http://loinc.org | Consultant Hospital Progress note
100566-9 | http://loinc.org | Dentistry Hospital Progress note
100567-7 | http://loinc.org | Dermatology Hospital Progress note
100568-5 | http://loinc.org | Developmental-behavioral pediatrics Hospital Progress note
100569-3 | http://loinc.org | Dialysis and Therapeutic apheresis Hospital Progress note
100570-1 | http://loinc.org | Eating disorders Hospital Progress note
100571-9 | http://loinc.org | Endocrinology Hospital Progress note
100572-7 | http://loinc.org | Family medicine Hospital Progress note
100573-5 | http://loinc.org | Gastroenterology Hospital Progress note
100574-3 | http://loinc.org | General medicine Hospital Progress note
100575-0 | http://loinc.org | Geriatric medicine Hospital Progress note
100576-8 | http://loinc.org | Gynecologic oncology Hospital Progress note
100577-6 | http://loinc.org | Gynecology Hospital Progress note
10057-8 | http://loinc.org | S wave duration in lead V6
100578-4 | http://loinc.org | Healthcare navigator Hospital Progress note
100579-2 | http://loinc.org | Heart failure Hospital Progress note
1005-8 | http://loinc.org | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma
100580-0 | http://loinc.org | Heart failure+Transplant cardiology Hospital Progress note
100581-8 | http://loinc.org | Hematology Hospital Progress note
100582-6 | http://loinc.org | Hematology+Medical oncology Hospital Progress note
100583-4 | http://loinc.org | Hepatology Hospital Progress note
100584-2 | http://loinc.org | Immunology Hospital Progress note
100585-9 | http://loinc.org | Infectious disease Hospital Progress note
10058-6 | http://loinc.org | S' wave amplitude in lead AVF
100586-7 | http://loinc.org | Internal medicine Hospital Progress note
100587-5 | http://loinc.org | Interventional cardiology Hospital Progress note
100588-3 | http://loinc.org | Interventional radiology Hospital Progress note
100589-1 | http://loinc.org | Hospital Mechanical circulatory support Progress note
100590-9 | http://loinc.org | Medical Aid in Dying Hospital Progress note
100591-7 | http://loinc.org | Mental health Hospital Progress note
100592-5 | http://loinc.org | Multi-specialty program Hospital Progress note
100593-3 | http://loinc.org | Neonatal perinatal medicine Hospital Progress note
10059-4 | http://loinc.org | S' wave amplitude in lead AVL
100594-1 | http://loinc.org | Nephrology Hospital Progress note
100595-8 | http://loinc.org | Neurological surgery Hospital Progress note
100596-6 | http://loinc.org | Neurology Hospital Progress note
100597-4 | http://loinc.org | Neurology with special qualifications in child neurology Hospital Progress note
100598-2 | http://loinc.org | Nurse practitioner Hospital Progress note
100599-0 | http://loinc.org | Nurse Hospital Progress note
100600-6 | http://loinc.org | Nutrition and dietetics Hospital Progress note
100601-4 | http://loinc.org | Obstetrics and Gynecology Hospital Progress note
10060-2 | http://loinc.org | S' wave amplitude in lead AVR
100602-2 | http://loinc.org | Obstetrics Hospital Progress note
100603-0 | http://loinc.org | Occupational therapy Hospital Progress note
100604-8 | http://loinc.org | Oncology Hospital Progress note
100605-5 | http://loinc.org | Ophthalmology Hospital Progress note
100606-3 | http://loinc.org | Oral and Maxillofacial Surgery Hospital Progress note
100607-1 | http://loinc.org | Orthopaedic surgery Hospital Progress note
100608-9 | http://loinc.org | Orthotics prosthetics Hospital Progress note
100609-7 | http://loinc.org | Otolaryngology Hospital Progress note
10061-0 | http://loinc.org | S' wave amplitude in lead I
100610-5 | http://loinc.org | Pain medicine Hospital Progress note
100611-3 | http://loinc.org | Palliative care Hospital Progress note
100612-1 | http://loinc.org | Pastoral care Hospital Progress note
100613-9 | http://loinc.org | Pediatric cardiology Hospital Progress note
100614-7 | http://loinc.org | Pediatric dermatology Hospital Progress note
100615-4 | http://loinc.org | Pediatric endocrinology Hospital Progress note
100616-2 | http://loinc.org | Pediatric gastroenterology Hospital Progress note
100617-0 | http://loinc.org | Pediatric hematology-oncology Hospital Progress note
100618-8 | http://loinc.org | Pediatric infectious diseases Hospital Progress note
100619-6 | http://loinc.org | Pediatric otolaryngology Hospital Progress note
100620-4 | http://loinc.org | Pediatric pulmonology Hospital Progress note
100621-2 | http://loinc.org | Pediatric rheumatology Hospital Progress note
100622-0 | http://loinc.org | Pediatric surgery Hospital Progress note
100623-8 | http://loinc.org | Pediatric transplant hepatology Hospital Progress note
100624-6 | http://loinc.org | Pharmacogenomics Hospital Progress note
100625-3 | http://loinc.org | Pharmacology Hospital Progress note
100626-1 | http://loinc.org | Physical medicine and rehab Hospital Progress note
100627-9 | http://loinc.org | Physical therapy Hospital Progress note
10062-8 | http://loinc.org | S' wave amplitude in lead II
100628-7 | http://loinc.org | Plastic surgery Hospital Progress note
100629-5 | http://loinc.org | Podiatry Hospital Progress note
100630-3 | http://loinc.org | Psychology Hospital Progress note
100631-1 | http://loinc.org | Radiation oncology Hospital Progress note
100632-9 | http://loinc.org | Radiology Hospital Progress note
100633-7 | http://loinc.org | Rapid response team Hospital Progress note
100634-5 | http://loinc.org | Recreational therapy Hospital Progress note
100635-2 | http://loinc.org | Reproductive endocrinology and infertility Hospital Progress note
10063-6 | http://loinc.org | S' wave amplitude in lead III
100636-0 | http://loinc.org | Research Hospital Progress note
100637-8 | http://loinc.org | Rheumatology Hospital Progress note
100638-6 | http://loinc.org | Sleep medicine Hospital Progress note
100639-4 | http://loinc.org | Social worker Hospital Progress note
100640-2 | http://loinc.org | Solid Organ Transplant Hospital Progress note
100641-0 | http://loinc.org | Speech-language pathology Hospital Progress note
100642-8 | http://loinc.org | Spinal surgery Hospital Progress note
100643-6 | http://loinc.org | Surgery of the hand Hospital Progress note
10064-4 | http://loinc.org | S' wave amplitude in lead V1
100644-4 | http://loinc.org | Thromboembolism Hospital Progress note
100645-1 | http://loinc.org | Trauma Hospital Progress note
100646-9 | http://loinc.org | Urology Hospital Progress note
100647-7 | http://loinc.org | Vascular neurology Hospital Progress note
100648-5 | http://loinc.org | Vascular surgery Hospital Progress note
100649-3 | http://loinc.org | Wound care management Hospital Progress note
100650-1 | http://loinc.org | Wound, Ostomy, and Continence Care Hospital Progress note
10065-1 | http://loinc.org | S' wave amplitude in lead V2
100651-9 | http://loinc.org | Hospital COVID-19 Intubation Progress note
100652-7 | http://loinc.org | Pure tone bone conduction threshold audiometry panel
100653-5 | http://loinc.org | Pure tone air conduction threshold audiometry panel
100654-3 | http://loinc.org | Pyruvate kinase M2 [Presence] in Stool
100655-0 | http://loinc.org | XR Sella turcica Lateral
100656-8 | http://loinc.org | Maternal and fetal medicine Outpatient Progress note
100657-6 | http://loinc.org | Maternal and fetal medicine Telephone encounter+Hospital Progress note
100658-4 | http://loinc.org | Hospital COVID-19 Progress note
100659-2 | http://loinc.org | Maternal and fetal medicine Hospital Progress note
1006-6 | http://loinc.org | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells
100660-0 | http://loinc.org | Maternal and fetal medicine Telephone encounter+Outpatient Progress note
100661-8 | http://loinc.org | Psychiatry Outpatient Progress note
100662-6 | http://loinc.org | Cortisol free and total panel - Serum or Plasma
100663-4 | http://loinc.org | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method
100664-2 | http://loinc.org | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method
100665-9 | http://loinc.org | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method
100666-7 | http://loinc.org | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method
100667-5 | http://loinc.org | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method
100668-3 | http://loinc.org | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method
10066-9 | http://loinc.org | S' wave amplitude in lead V3
100669-1 | http://loinc.org | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method
100670-9 | http://loinc.org | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus
100671-7 | http://loinc.org | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection
100672-5 | http://loinc.org | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection
100673-3 | http://loinc.org | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection
100674-1 | http://loinc.org | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100675-8 | http://loinc.org | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
100676-6 | http://loinc.org | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection
10067-7 | http://loinc.org | S' wave amplitude in lead V4
100677-4 | http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
100678-2 | http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100679-0 | http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
100680-8 | http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100681-6 | http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
100682-4 | http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100683-2 | http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
100684-0 | http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
10068-5 | http://loinc.org | S' wave amplitude in lead V5
100685-7 | http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
100686-5 | http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
100687-3 | http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection
100688-1 | http://loinc.org | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100689-9 | http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection
100690-7 | http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection
100691-5 | http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100692-3 | http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
10069-3 | http://loinc.org | S' wave amplitude in lead V6
100693-1 | http://loinc.org | Pneumocystis jirovecii DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection
100694-9 | http://loinc.org | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method
100695-6 | http://loinc.org | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative
100696-4 | http://loinc.org | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal
100697-2 | http://loinc.org | Interventional radiology Outpatient Note
100698-0 | http://loinc.org | Social Determinants of Health screening report Document
100699-8 | http://loinc.org | Rifabutin+Ethambutol [Susceptibility]
100700-4 | http://loinc.org | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection
10070-1 | http://loinc.org | S' wave duration in lead AVF
100701-2 | http://loinc.org | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection
100702-0 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection
100703-8 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection
100704-6 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection
100705-3 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection
100706-1 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection
100707-9 | http://loinc.org | Granulocytes [#/volume] in Peritoneal dialysis fluid by Automated count
100708-7 | http://loinc.org | Plasma cells/Leukocytes in Synovial fluid
100709-5 | http://loinc.org | Hepatocellular carcinoma risk [Score] by GAAD
100710-3 | http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection
100711-1 | http://loinc.org | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay
100712-9 | http://loinc.org | Brexpiprazole [Mass/volume] in Serum or Plasma
100713-7 | http://loinc.org | Cariprazine [Mass/volume] in Serum or Plasma
100714-5 | http://loinc.org | Guanfacine [Mass/volume] in Serum or Plasma
100715-2 | http://loinc.org | Prothipendyl [Mass/volume] in Serum or Plasma
100716-0 | http://loinc.org | Prostate specific Ag [Mass/volume] in DBS
100717-8 | http://loinc.org | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method
100718-6 | http://loinc.org | Undersea and hyperbaric medicine Discharge summary
10071-9 | http://loinc.org | S' wave duration in lead AVL
100719-4 | http://loinc.org | Surgical oncology Discharge summary
100720-2 | http://loinc.org | Reproductive endocrinology and infertility Discharge summary
100721-0 | http://loinc.org | Community health care Discharge summary
100722-8 | http://loinc.org | Integrative medicine Discharge summary
100723-6 | http://loinc.org | Sports medicine Discharge summary
100724-4 | http://loinc.org | Diabetology Discharge summary
100725-1 | http://loinc.org | Optometry Discharge summary
100726-9 | http://loinc.org | Podiatry Discharge summary
10072-7 | http://loinc.org | S' wave duration in lead AVR
100727-7 | http://loinc.org | Chiropractic medicine Discharge summary
100728-5 | http://loinc.org | Cardiac surgery Discharge summary
100729-3 | http://loinc.org | Breastfeeding Discharge summary
100730-1 | http://loinc.org | Transplant surgery Discharge summary
100731-9 | http://loinc.org | Urgent care center Discharge summary
100732-7 | http://loinc.org | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum
100733-5 | http://loinc.org | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a)
100734-3 | http://loinc.org | traMADol and Metabolites Panel - Urine by Confirmatory method
10073-5 | http://loinc.org | S' wave duration in lead I
100735-0 | http://loinc.org | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes
100736-8 | http://loinc.org | Acylcarnitine Analysis Post Mortem in Specimen Document
100737-6 | http://loinc.org | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma
100738-4 | http://loinc.org | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma
100739-2 | http://loinc.org | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma
1007-4 | http://loinc.org | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
100740-0 | http://loinc.org | Amylase.macromolecular [Presence] in Serum or Plasma
100741-8 | http://loinc.org | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma
100742-6 | http://loinc.org | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma
10074-3 | http://loinc.org | S' wave duration in lead II
100743-4 | http://loinc.org | Lipase.macromolecular [Presence] in Serum or Plasma
100744-2 | http://loinc.org | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis
100745-9 | http://loinc.org | Chloride [Moles/volume] in Mixed venous blood
100746-7 | http://loinc.org | Glucose [Moles/volume] in Mixed venous blood
100747-5 | http://loinc.org | Legionella serogroup panel - Specimen
100748-3 | http://loinc.org | Legionella spp [Presence] in Specimen by NAA with probe detection
100749-1 | http://loinc.org | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection
10075-0 | http://loinc.org | S' wave duration in lead III
100750-9 | http://loinc.org | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection
100751-7 | http://loinc.org | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma
100752-5 | http://loinc.org | Exacerbating factors - Reported
100753-3 | http://loinc.org | Alleviating factors - Reported
100754-1 | http://loinc.org | Platelet disorders multigene analysis in Blood or Tissue by Sequencing
100755-8 | http://loinc.org | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing
100756-6 | http://loinc.org | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing
100757-4 | http://loinc.org | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing
100758-2 | http://loinc.org | Estimated lung age by based on clinical data
100759-0 | http://loinc.org | Inspiratory reserve [Volume] Respiratory system by Spirometry
100760-8 | http://loinc.org | XR Radius and Ulna - left Single view
100761-6 | http://loinc.org | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
100762-4 | http://loinc.org | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method
100763-2 | http://loinc.org | Mycobacterium sp comparative reaction interpretation Narrative
100764-0 | http://loinc.org | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal
100765-7 | http://loinc.org | Homocysteine and methylmalonate and methylcitrate panel - DBS
100766-5 | http://loinc.org | Center for Epidemiologic Studies Depression Scale panel [CES-D]
100767-3 | http://loinc.org | Bothered by things that are not usually bothersome
10076-8 | http://loinc.org | S' wave duration in lead V1
100768-1 | http://loinc.org | Poor appetite
100769-9 | http://loinc.org | Unhappy even with help from my family or friends
100770-7 | http://loinc.org | Feeling just as good as others
100771-5 | http://loinc.org | Trouble focusing
100772-3 | http://loinc.org | Feeling depressed
100773-1 | http://loinc.org | Feeling everything is too much of an effort
100774-9 | http://loinc.org | Feeling hopeful about the future
100775-6 | http://loinc.org | Feeling life had been a failure
10077-6 | http://loinc.org | S' wave duration in lead V2
100776-4 | http://loinc.org | Feeling fearful
100777-2 | http://loinc.org | Restless sleep
100778-0 | http://loinc.org | Feeling happy
100779-8 | http://loinc.org | Quieter than usual
100780-6 | http://loinc.org | Feeling lonely
100781-4 | http://loinc.org | People were unfriendly
100782-2 | http://loinc.org | Enjoying life
100783-0 | http://loinc.org | Crying spells
10078-4 | http://loinc.org | S' wave duration in lead V3
100784-8 | http://loinc.org | Feeling sad
100785-5 | http://loinc.org | Feeling people dislike me
100786-3 | http://loinc.org | Lack of energy
100787-1 | http://loinc.org | Total Score CES-D
100788-9 | http://loinc.org | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum
100789-7 | http://loinc.org | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum
100790-5 | http://loinc.org | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum
100791-3 | http://loinc.org | Hamster epithelium IgG Ab [Mass/volume] in Serum
10079-2 | http://loinc.org | S' wave duration in lead V4
100792-1 | http://loinc.org | Forsythia IgE Ab [Units/volume] in Serum
100793-9 | http://loinc.org | Testosterone [Mass/volume] in Body fluid
100794-7 | http://loinc.org | Follitropin [Units/volume] in Body fluid
100795-4 | http://loinc.org | S100 calcium binding protein B [Mass/volume] in Body fluid
100796-2 | http://loinc.org | Thyroglobulin [Mass/volume] in Body fluid
100797-0 | http://loinc.org | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge
100798-8 | http://loinc.org | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge
100799-6 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge
100-8 | http://loinc.org | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
10080-0 | http://loinc.org | S' wave duration in lead V5
100800-2 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge
100801-0 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge
100802-8 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge
100803-6 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge
100804-4 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge
100805-1 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge
100806-9 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge
100807-7 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge
100808-5 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge
100809-3 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge
100810-1 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge
100811-9 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge
100812-7 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge
100813-5 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge
100814-3 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge
100815-0 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge
100816-8 | http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
100817-6 | http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
10081-8 | http://loinc.org | S' wave duration in lead V6
100818-4 | http://loinc.org | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge
100819-2 | http://loinc.org | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge
1008-2 | http://loinc.org | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma
100820-0 | http://loinc.org | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge
100821-8 | http://loinc.org | National POLST form: portable medical order panel
100822-6 | http://loinc.org | Cardiopulmonary resuscitation orders
100823-4 | http://loinc.org | Initial portable medical treatment orders
100824-2 | http://loinc.org | Additional portable medical orders or instructions
100825-9 | http://loinc.org | Medically assisted nutrition orders
10082-6 | http://loinc.org | ST initial amplitude 6 ms in lead AVF
100826-7 | http://loinc.org | Portable medical order AndOr advance directive review
100827-5 | http://loinc.org | Portable medical order discussion participants
100828-3 | http://loinc.org | Portable medical order administrative information
100829-1 | http://loinc.org | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge
100830-9 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
100831-7 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
100832-5 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
100833-3 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
10083-4 | http://loinc.org | ST initial amplitude 6 ms in lead AVL
100834-1 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
100835-8 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
100836-6 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
100837-4 | http://loinc.org | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
100838-2 | http://loinc.org | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
100839-0 | http://loinc.org | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma
100840-8 | http://loinc.org | IgE [Units/volume] in Body fluid
100841-6 | http://loinc.org | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot
10084-2 | http://loinc.org | ST initial amplitude 6 ms in lead AVR
100842-4 | http://loinc.org | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST
100843-2 | http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+
100844-0 | http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile4
100845-7 | http://loinc.org | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC)
100846-5 | http://loinc.org | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay
100847-3 | http://loinc.org | Gas and ammonia panel - Arterial blood
100848-1 | http://loinc.org | Cell count and Differential panel - Amniotic fluid by Manual count
100849-9 | http://loinc.org | Leukocytes [#/volume] in Amniotic fluid by Manual count
100850-7 | http://loinc.org | Neutrophils [#/volume] in Amniotic fluid by Manual count
100851-5 | http://loinc.org | Other cells [#/volume] in Amniotic fluid by Manual count
100852-3 | http://loinc.org | NM Bones Views for metastasis W Sr-89 IV
100853-1 | http://loinc.org | NM Pericardial space Pericardial effusion
100854-9 | http://loinc.org | Lymphocytes/cells in Blood mononuclear cells by Immunoassay
100855-6 | http://loinc.org | CD3 cells/cells in Blood mononuclear cells
100856-4 | http://loinc.org | CD3+CD4+ (T4 helper) cells/cells in Blood mononuclear cells
100857-2 | http://loinc.org | CD3+CD8+ (T8 suppressor) cells/cells in Blood mononuclear cells
100858-0 | http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
10085-9 | http://loinc.org | ST initial amplitude 6 ms in lead I
100859-8 | http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
100860-6 | http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
100861-4 | http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
100862-2 | http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
100863-0 | http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
100864-8 | http://loinc.org | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method
100865-5 | http://loinc.org | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection
100866-3 | http://loinc.org | Febrile antibody profile in Serum
10086-7 | http://loinc.org | ST initial amplitude 6 ms in lead II
100867-1 | http://loinc.org | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay
100868-9 | http://loinc.org | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method
100869-7 | http://loinc.org | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method
100870-5 | http://loinc.org | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method
100871-3 | http://loinc.org | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method
100872-1 | http://loinc.org | Bacteria producing polysaccharide from sucrose [Presence] in Isolate
100873-9 | http://loinc.org | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method
100874-7 | http://loinc.org | Basidiobolus sp [Presence] in Specimen
10087-5 | http://loinc.org | ST initial amplitude 6 ms in lead III
100875-4 | http://loinc.org | Fetal Heart Document limited US
100876-2 | http://loinc.org | Fetal Heart Document US
100877-0 | http://loinc.org | US Heart Transesophageal during surgery
100878-8 | http://loinc.org | Endoscopic ultrasound study Upper GI tract Document
100879-6 | http://loinc.org | US Guidance for cryoablation of Breast - right
100880-4 | http://loinc.org | US Guidance for cryoablation of Breast - left
100881-2 | http://loinc.org | MR Guidance for cryoablation of Bone
100882-0 | http://loinc.org | MR Peritoneum W contrast percutaneous intraperitoneal
10088-3 | http://loinc.org | ST initial amplitude 6 ms in lead V1
100883-8 | http://loinc.org | MR Guidance for biopsy of Kidney - left
100884-6 | http://loinc.org | MR Guidance for biopsy of Kidney - right
100885-3 | http://loinc.org | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection
100886-1 | http://loinc.org | Orf virus DNA [Presence] in Specimen by NAA with probe detection
100887-9 | http://loinc.org | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection
100888-7 | http://loinc.org | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection
100889-5 | http://loinc.org | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection
100890-3 | http://loinc.org | Poxvirus DNA panel
10089-1 | http://loinc.org | ST initial amplitude 6 ms in lead V2
100891-1 | http://loinc.org | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay
100892-9 | http://loinc.org | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
100893-7 | http://loinc.org | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma
100894-5 | http://loinc.org | Recommended screening frequency Narrative
100895-2 | http://loinc.org | Rickettsia conorii IgG and IgM [Interpretation] in Serum
100896-0 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge
100897-8 | http://loinc.org | Staphylococcus aureus [Presence] in Specimen by Organism specific culture
100898-6 | http://loinc.org | Lipid panel - Serum or Plasma
100899-4 | http://loinc.org | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture

Explanation of the columns that may appear on this page:

Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System | The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code | The code (used as the code in the resource instance)
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition | An explanation of the meaning of the concept
Comments | Additional notes about how to use the code